Journal of Practical Hepatology ›› 2023, Vol. 26 ›› Issue (4): 601-604.doi: 10.3969/j.issn.1672-5069.2023.04.038
Previous Articles Next Articles
Li Zhongzhe, Liao Hui, Xu Xiaoping
Received:
2022-03-16
Online:
2023-07-10
Published:
2023-07-21
Li Zhongzhe, Liao Hui, Xu Xiaoping. Nutrition assessment and diet management in patients with liver cirrhosis[J]. Journal of Practical Hepatology, 2023, 26(4): 601-604.
[1] 徐小元, 丁惠国, 李文刚, 等. 肝硬化诊治指南. 实用肝脏病杂志, 2019,22(6):770-786. [2] Nishikawa H, Enomoto H, Nishiguchi S, et al. Sarcopenic obesity in liver cirrhosis: possible mechanism and clinical impact. Int J Mol Sci, 2021,22(4):1917. [3] Sasidharan M, Nistala S, Narendhran RT, et al. Nutritional status and prognosis in cirrhotic patients. Trop Gastroenterol, 2012,33(4):257-264. [4] Kalafateli M, Mantzoukis K, Choi Yau Y, et al. Malnutrition and sarcopenia predict post-liver transplantation outcomes independently of the model for end-stage liver disease score. J Cachexia Sarcopenia Muscle, 2017,8(1):113-121. [5] Fernandes SA, Leonhardt LR, da Silva DM, et al. Bioelectrical impedance vector analysis evaluates cellularity and hydration in cirrhotic patients. World J Hepatol, 2020,12(12):1276-1288. [6] 杨晓玲, 张素梅. SGA、MNA和NRS2002评估失代偿期肝硬化患者营养状态应用价值分析. 实用肝脏病杂志, 2020,23(1):70-73. [7] Georgiou A, Papatheodoridis GV, Alexopoulou A, et al. Evaluation of the effectiveness of eight screening tools in detecting risk of malnutrition in cirrhotic patients: the KIRRHOS study. Br J Nutr, 2019,122(12):1368-1376. [8] Sinclair M, Chapman B, Hoermann R, et al. Handgrip strength adds more prognostic value to the model for end-stage liver disease score than imaging-based measures of muscle mass in men with cirrhosis. Liver Transpl, 2019,25(10):1480-1487. [9] Schweitzer L, Geisler C, Pourhassan M, et al. What is the best reference site for a single MRI slice to assess whole-body skeletal muscle and adipose tissue volumes in healthy adults? Am J Clin Nutr, 2015,102(1):58-65. [10] 石志文, 李娟, 曾欣, 等. L_3骨骼肌指数在疾病预后评估中的应用. 第二军医大学学报, 2019,40(4):420-425. [11] Traub J, Reiss L, Aliwa B, et al. Malnutrition in patients with liver cirrhosis. Nutrients, 2021,13(2):540. [12] Ribeiro HS, Mauricio SF, Antônio da Silva T, et al. Combined nutritional assessment methods to predict clinical outcomes in patients on the waiting list for liver transplantation. Nutrition, 2018,47:21-26. [13] Maharshi S, Sharma BC, Srivastava S. Malnutrition in cirrhosis increases morbidity and mortality. J Gastroenterol Hepatol, 2015,30(10):1507-1513. [14] Chaney A, Rawal B, Harnois D, et al. Nutritional assessment and malnutrition in patients with cirrhosis. Gastroenterol Nurs, 2020,43(4):284-291. [15] Müller MJ, Böttcher J, Selberg O, et al. Hypermetabolism in clinically stable patients with liver cirrhosis. Am J Clin Nutr, 1999,69(6):1194-1201. [16] Lai JC, Tandon P, Bernal W, et al. Malnutrition, frailty, and sarcopenia in patients with cirrhosis: 2021 practice guidance by the American association for the study of liver diseases. Hepatology, 2021,74(3):1611-1644. [17] Merli M, Berzigotti A, Zelber-Sagi S, et al. EASL clinical practice guidelines on nutrition in chronic liver disease. J Hepatol, 2019,70(1):172-193. [18] Bajaj JS, Lauridsen M, Tapper EB, et al. Important unresolved questions in the management of hepatic encephalopathy: an ISHEN consensus. Am J Gastroenterol, 2020,115(7):989-1002. [19] Bischoff SC, Bernal W, Dasarathy S, et al. ESPEN practical guideline: clinical nutrition in liver disease. Clin Nutr, 2020,39(12):3533-3562. [20] Palmese F, Bolondi I, Giannone FA, et al. The analysis of food intake in patients with cirrhosis waiting for liver transplantation: a neglected step in the nutritional assessment. Nutrients, 2019,11(10):2462. [21] Mieszkowski J, Stankiewicz BE, Kochanowicz A, et al. Remote ischemic preconditioning reduces marathon-induced oxidative stress and decreases liver and heart injury markers in the serum. Front Physiol, 2021,12:731889. [22] Toshikuni N, Arisawa T, Tsutsumi M. Nutrition and exercise in the management of liver cirrhosis. World J Gastroenterol, 2014,20(23):7286-7297. [23] Properzi C, O'Sullivan TA, Sherriff JL, et al. Ad libitum mediterranean and low‐fat diets both significantly reduce hepatic steatosis: A randomized controlled trial. Hepatology, 2018,68(5):1741-1754. [24] Baratta F, Pastori D, Polimeni L, et al. Adherence to mediterranean diet and non-alcoholic fatty liver disease: effect on insulin resistance. Am J Gastroenterol, 2017,112(12):1832-1839. [25] Yaskolka Meir A, Rinott E, Tsaban G, et al. Effect of green-Mediterranean diet on intrahepatic fat: the DIRECT PLUS randomised controlled trial. Gut, 2021,70(11):2085-2095. [26] Romero-Gómez M, Zelber-Sagi S, Trenell M. Treatment of NAFLD with diet, physical activity and exercise. J Hepatol, 2017,67(4):829-846. [27] Ruiz-Margáin A, Macías-Rodríguez RU, Ríos-Torres SL, et al. Effect of a high-protein, high-fiber diet plus supplementation with branched-chain amino acids on the nutritional status of patients with cirrhosis. Rev Gastroenterol Mex (Engl Ed), 2018,83(1):9-15. [28] Les I, Doval E, García-Martínez R, et al. Effects of branched-chain amino acids supplementation in patients with cirrhosis and a previous episode of hepatic encephalopathy: a randomized study. Am J Gastroenterol, 2011,106(6):1081-1088. [29] 于健春, 陈伟, 江华, 等. 多种微量元素制剂临床应用专家共识. 中华外科杂志, 2018,56(3):168-176. [30] 高纯, 李梦, 韦军民, 等. 复方氨基酸注射液临床应用专家共识. 肿瘤代谢与营养电子杂志, 2019,6(2):183-189. [31] 段钟平, 杨云生. 终末期肝病临床营养指南. 中华肝脏病杂志, 2019,27(5):330-342. [32] 侯维, 蒋朱明, 杨剑, 等. 慢性肝病患者肠外肠内营养支持与膳食干预专家共识. 中华肝胆外科杂志, 2017,23(2):73-81. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||